Skip to main content
Clinical Trials/NCT00006435
NCT00006435
Completed
Not Applicable

Natural History of Plexiform in Neurofibromatosis Type I

National Cancer Institute (NCI)1 site in 1 country24 target enrollmentMay 18, 2001

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Plexiform Neurofibromas
Sponsor
National Cancer Institute (NCI)
Enrollment
24
Locations
1
Primary Endpoint
Monitor natural history of plexiform neurofibromas
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

Background:

-Plexiform neurofibromas in patients with NF1 are a significant cause of morbidity but little is known about the natural history of these lesions.

Objectives:

  • The purpose of this study is to monitor the natural history of plexiform neurofibromas and to evaluate the usefulness of volumetric MRI tumor measurements in this disease.
  • Other goals of the study are to provide a body of normative data on the growth rate of plexiform neurofibromas and to establish a tissue repository and pathology review center to allow future studies of the pathogenesis of neurofibromas and clinical trials of potential therapeutic agents.

Design

  • This study is coordinated by Dr. Bruce Korf, and was initiated when he was at the Partners Center for Human Genetics, Boston, MA.

Detailed Description

Background: -Plexiform neurofibromas in patients with NF1 are a significant cause of morbidity but little is known about the natural history of these lesions. Objectives: * The purpose of this study is to monitor the natural history of plexiform neurofibromas and to evaluate the usefulness of volumetric MRI tumor measurements in this disease. * Other goals of the study are to provide a body of normative data on the growth rate of plexiform neurofibromas and to establish a tissue repository and pathology review center to allow future studies of the pathogenesis of neurofibromas and clinical trials of potential therapeutic agents. Design - This study is coordinated by Dr. Bruce Korf, and was initiated when he was at the Partners Center for Human Genetics, Boston, MA.

Registry
clinicaltrials.gov
Start Date
May 18, 2001
End Date
May 1, 2020
Last Updated
5 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Monitor natural history of plexiform neurofibromas

Time Frame: 3 years

Monitor natural history of plexiform neurofibromas

Usefulness of volumetric MRI measurements

Time Frame: 4 years

Usefulness of volumetric MRI measurements

Secondary Outcomes

  • Establish tissue repository & pathology reviews center(3 years)
  • Body of data regarding growth rate of plexiform neurofibromas(3 years)

Study Sites (1)

Loading locations...

Similar Trials